Raloxifene hydrochloride
- Product NDC
- 50090-3363
- Requested package NDC
- 50090-3363-0
- 11-digit product format
- 500903363
- Labeler code
- 50090
- Product ID
- 50090-3363_98e0318f-6b3a-4274-ae25-5bb9ee5b6bc6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Raloxifene hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA206384
- Marketing category
- ANDA
- Marketing start
- 2016-10-12
- Marketing end
- 0000-00-00
- Substance
- RALOXIFENE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-3363 | 50090-3363-0 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206384-001 | RALOXIFENE HYDROCHLORIDE | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2016-10-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206384-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206384-001 | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2016-10-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206384-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Major Pharmaceuticals | e2967d3c-238c-40cf-b3d8-89482a502928 | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Bryant Ranch Prepack | ad3ef791-ac90-4f66-8da6-95b31e4c3eb6 | 2023-03-30 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | ScieGen Pharmaceuticals Inc | 8152e68b-61a8-4897-8e03-900135b1dbd5 | 2023-01-09 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Dr.Reddys Laboratories Inc | 8f24455c-34dc-4e07-bcd3-24326b9cc377 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 6fd63a06-5bc5-4c50-9b85-b09c89100b80 | 2018-04-27 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7ad62b49-6132-2a8c-4edd-73f39b2bf45c | Product name | 6 | 20210312 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3363-0 | Raloxifene hydrochloride | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 1 | |
| 50090-3363-1 | Raloxifene hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3363-0 | EA - Each | 50090-3363 | 55e462d3-0386-4f1b-95e1-5dd0215603ec | 1 | 2019-05-02 |
| 50090-3363-1 | EA - Each | 50090-3363 | 22a9724b-7825-4461-a1b1-f21518758b4b | 1 | 2019-05-02 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3363 | RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 1 | Legacy NDC, 2 package rows | 20190205_de746495-e92f-48c1-824e-56ca9401f2a0.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1490065 | raloxifene HCl 60 MG Oral Tablet | PSN | de746495-e92f-48c1-824e-56ca9401f2a0 | 1 |
| 1490065 | raloxifene hydrochloride 60 MG Oral Tablet | SCD | de746495-e92f-48c1-824e-56ca9401f2a0 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-3363-0 | 50090336300 | 100 TABLET, FILM COATED in 1 BOTTLE (50090-3363-0) | 2018-02-07 | 0000-00-00 | No | No | Current |